Barclays’s Sharps Compliance Corp SMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-22,845
| Closed | -$67K | – | 5340 |
|
|
2022
Q2 | $67K | Sell |
22,845
-3,053
| -12% | -$12.7K | ﹤0.01% | 3937 |
|
|
2022
Q1 | $153K | Sell |
25,898
-19,455
| -43% | -$122K | ﹤0.01% | 3580 |
|
|
2021
Q4 | $324K | Buy |
45,353
+16,534
| +57% | +$127K | ﹤0.01% | 3386 |
|
|
2021
Q3 | $238K | Buy |
28,819
+24,864
| +629% | +$231K | ﹤0.01% | 3531 |
|
|
2021
Q2 | $42K | Sell |
3,955
-13,906
| -78% | -$194K | ﹤0.01% | 4219 |
|
|
2021
Q1 | $256K | Sell |
17,861
-5,159
| -22% | -$66.4K | ﹤0.01% | 3590 |
|
|
2020
Q4 | $218K | Buy |
23,020
+16,520
| +254% | +$126K | ﹤0.01% | 3711 |
|
|
2020
Q3 | $41K | Sell |
6,500
-1,301
| -17% | -$9.46K | ﹤0.01% | 4698 |
|
|
2020
Q2 | $54K | Buy |
+7,801
| New | +$55.5K | ﹤0.01% | 4901 |
|
|
2019
Q4 | – | Sell |
-61
| Closed | – | – | 7014 |
|
|
2019
Q3 | $0 | Buy |
+61
| New | +$231 | ﹤0.01% | 7305 |
|
|
2019
Q2 | – | Sell |
-1,338
| Closed | -$5K | – | 7433 |
|
|
2019
Q1 | $5K | Hold |
1,338
| – | – | ﹤0.01% | 6728 |
|
|
2018
Q4 | $5K | Sell |
1,338
-48
| -3% | -$165 | ﹤0.01% | 6476 |
|
|
2018
Q3 | $5K | Buy |
1,386
+48
| +4% | +$169 | ﹤0.01% | 6805 |
|
|
2018
Q2 | $5K | Buy |
1,338
+1,248
| +1,387% | +$4.92K | ﹤0.01% | 6717 |
|
|
2018
Q1 | $0 | Buy |
90
+89
| +8,900% | +$399 | ﹤0.01% | 7449 |
|
|
2017
Q4 | $0 | Buy |
+1
| New | +$4 | ﹤0.01% | 7207 |
|
|
2017
Q2 | – | Sell |
-29
| Closed | – | – | 7052 |
|
|
2017
Q1 | $0 | Sell |
29
-62
| -68% | -$285 | ﹤0.01% | 7073 |
|
|
2016
Q4 | $0 | Hold |
91
| – | – | ﹤0.01% | 6922 |
|
|
2016
Q3 | $0 | Hold |
91
| – | – | ﹤0.01% | 6877 |
|
|
2016
Q2 | $0 | Sell |
91
-17,000
| -99% | -$80.4K | ﹤0.01% | 6736 |
|
|
2016
Q1 | $85K | Sell |
17,091
-16,109
| -49% | -$97.7K | ﹤0.01% | 4462 |
|
|
2015
Q4 | $266K | Buy |
33,200
+26,200
| +374% | +$227K | ﹤0.01% | 3685 |
|
|
2015
Q3 | $56K | Buy |
+7,000
| New | +$50.6K | ﹤0.01% | 4967 |
|
Barclays's SMED Position: Q3 2022 in Review
Barclays sold out of Sharps Compliance Corp (SMED) in Q3 2022, closing a stake of 22,845 shares — an estimated $67K sold.
Barclays first reported a position in SMED in Q3 2015 and held it in 23 quarters. The position peaked at $324K in Q4 2021. 0 funds tracked by Wall St. Rank hold SMED as of Q3 2022.
- Barclays reported no remaining Sharps Compliance Corp position as of Q3 2022 after selling out during the quarter.
- Barclays sold 22,845 Sharps Compliance Corp shares in Q3 2022, an estimated $67K.
- Barclays first reported a position in Sharps Compliance Corp in Q3 2015 and held it in 23 quarters.
- Barclays's Sharps Compliance Corp position peaked at $324K in Q4 2021.
- 0 funds tracked by Wall St. Rank held Sharps Compliance Corp as of Q3 2022.
Based on Barclays's 13F filing for Q3 2022, filed 3 Nov 2022.